We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAS North Atlantic Smaller Companies Investment Trust Plc

130.00 (3.27%)
12 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
North Atlantic Smaller Companies Investment Trust Plc LSE:NAS London Ordinary Share GB0006439003 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  130.00 3.27% 4,100.00 4,030.00 4,070.00 4,080.00 3,960.00 3,960.00 4,979 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 11.28M 2.15M 0.1605 251.09 531.28M
North Atlantic Smaller Companies Investment Trust Plc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker NAS. The last closing price for North Atlantic Smaller C... was 3,970p. Over the last year, North Atlantic Smaller C... shares have traded in a share price range of 3,420.00p to 4,240.00p.

North Atlantic Smaller C... currently has 13,382,290 shares in issue. The market capitalisation of North Atlantic Smaller C... is £531.28 million. North Atlantic Smaller C... has a price to earnings ratio (PE ratio) of 251.09.

North Atlantic Smaller C... Share Discussion Threads

Showing 426 to 449 of 625 messages
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older
They'd had those T Bills for yonks - hopefully sold near the peak, and interesting to know what's been bought (& whether bought pre-Ukraine).
US Treasury bills no longer in the top 10 list having been 7 - 10% of the fund 6 months ago so must have made some investments in the falling markets, hope this works out and we don't end up in recession by the end of this year.
A far superior CM - Charlie Munger - still going at 98 in fairness.

The great Tony Pidgley left us at 72 mind.

rambutan. Worth noting legends like PS are now in their Seventies..

Not many bright young things coming through on the Fund Management front.

Most fund management cos are about protecting the assets under management for the fees- not gains for clients.

Let's hope he doesn't age like Putin and start invading, oh I don't know, FCRM.
30% discount to NAV at end of Jan with plenty of cash to take advantages of opportunities. Added a few but been here for over a decade so have enough tucked away.

Also CM isn’t a spring chicken any more.

topvest, the esteemed Peter Spiller of CGT, who is certainly not a fan of high fees, has held NAS for decades. He says it's a way of accessing private equity and associated skills on the cheap...
So, nav down approx 5% in Jan:

The Board announces that as at 31 January 2022 the unaudited net asset value per share (excluding current period revenue) under the equity accounting method was 5,846.96p.

The unaudited net asset value per share quoted above differs from that required under IFRS 10, which was adopted by the Company from 1 February 2014 as detailed in its Half Yearly Financial Report for the six months ended 31 July 2014. The unaudited net asset value per share (excluding current period revenue) under IFRS 10 was 5,769.79p.

You have to pay for Christopher Mills, but his long-term record has shown that he is well worth the money.
Holding Oryx means Mills gets to double dip on fees.
anybody cares to comment whether this is good entry point- big discount but good historical performance. I am intrigued where does it invest apart form the uk;
anyone know why they hold oryx growth fund which mirrors many of their holdings? it's quite rare to get a trust with this sort of record trading at such a discount.
Given the drop in UK small caps almost across the board the NAV will have to have dropped a bit. Renalytx is down to 464 from a high of around 1200 for example.
Not sure what the current NAV is but have been accumulating a few more for the bottom drawer.
Thanks @Spartacus. A few buy-backs to factor in too, but likely within the margin of error.

Perhaps coincidentally, HL has the 12 month average discount at 25.99%.

I make the running NAV today to be about £58 down 6% from the Dec 31st number. Implying a discount of c.25% to today's SP

Big Mills portfolio losers in the recent sell off have been the big growth holdings such as Polar, EKF, Renalytix and Oyrx.

Surprisingly good performances from Hargreaves, MJ Gleeson, Odyssean, Circassia and SureServe

My rudimentary model gets a bit less certain at this time of the year because we don’t have much recent details of the holdings below the top 10 – for which we are awaiting the end of year report to Jan 31st which normally surfaces in May.

I would hope that Mills has been in the market over the last couple of days. There is £100m+ cash available so plenty of firepower and perhaps some bargains to be found.

At a 25% discount NAS continues to be outstanding value.

spartacus mills
Wonder what the current NAV is - considering the number of listed holdings, a daily NAV wouldn't go amiss IMO.

Looking for an excuse to buy back in.

Pink - you seem to be implying buybacks are already limited (or maybe I misunderstood). Based on the latest waiver, there is still room to repurchase over 1m shares. There continue to be votes against the waiver, but they have been a minority. The team has been working hard for ages (see my posts above) to try to get the naysayers to see sense.
We need to make sure we vote....

first sorry for the duplicate post everyone
loglorry - quite a few different points over the 2 posts. Though the latter one was primarily to update on the NAV, and ask if Spartacus has an uptodate guesstimate.
Yes the FTSE small cap fell almost as much in November. And ex Renalytix NAS outperformed.

At first sight it's quite hard to square Mills' immense bullishness on a lot of his holdings with his cautious view and holding lots of cash. However, I think I can broadly defend a consistency - most of the names he mentioned on the recent call are small or very small and there is a limit to how much cash NAS can be deploy in them. If asked, he would probably say it is harder to find value among the mid-cap names that would tend to be larger holdings. And of course he is making a general remark about the UK market (and beyond) as a whole.

Posted the below on Fulcrum pbb. Harwood not covered themselves in glory on that one so far.

"Just some thoughts.

A) obviously an attempt at buy and build in MAP and any buy and build is always risky.

B) debt risk as they mention increasing it, *optimised", or something along those lines. See C).

C) might optimised debt on cash generative assets be via a CLN (convertible loan notes) and big holders might love that. Revolving credit facility via bank, investment debt via CLN arrangement, "optimised". Optimised for whom? Debt holders get preferential treatment on any liquidation risk. Bayford & Harwood offering debt would give them income, some protection and equity upside over time - could take quite a while? Very optimised especially as rates are so low currently and there is cash waiting to be allocated. Tax on profit due to rise to 25% April 2023 onwards. Debt offered by large equity owners squares more than one circle. "optimised".

D) for now share price appreciation might not be the main target of the large holders - interest income via offering debt might be. Think about that, especially if pis are locked out of offering debt. I don't think Bayford & Harwood are necessarily playing the same game with the same goal as ordinary pis. They have incentives that could be outside of near time equity value increases via share price.

E) The other point is what about post, about, January 12th. The new shares hit the market and any upside will be limited as pis look to take some cash out on any increase.

F) In fact upside might be limited until both the acquisitions are clarified (uncertainty) and the debt level and type made clear. Both are big unknowns.

Just thoughts, dyor etc. Imho.

Convertible loan notes make sense for the large holders and Harwood are clever.
Whatever happens, debt is due to increase according to the rns release and I don't see why the bank should benefit."

Would rather ride it out here than take a chance of exiting and not getting back in lower or even the same price. This has become a keeper for me having held quite a while. £40 -£50 is probably the range barring ability to increase buybacks or some other interesting event in the portfolio.
Posts 272,3,4 from August is point we have arrived at and mentioned in the last set of results. Buyback limitations will hinder supporting the share price

Mills chance to allocate more capital will come and might be as a result of US tightening feeding through into a period of greater volatility and weakness.

A 4% drop on NAV is probably a big out performance against the small/mid cap index. It will be lower for the end of December too. I'm not sure what your point is? Mills thinks stock prices have run up too much which is why he holds a lot of cash and has been buying back stock.

As far as I can tell he is performing well in a soft market.

Just realised my post just after NAS announced the NAV didn't stick:
QUOTE: Renalytix a bit of a shock I guess; makes the massive buyback look unfortunately timed. End Nov NAV down almost 4% to £61.1 (despite buyback impact). Not losing faith, but not really looking to add. A whole bunch of trusts with c. 30% upside to realtime NAV, though I am always interested to hear Spartacus' latest estimate, and whether there is any offset to the continued drop in renalytix.

Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older

Your Recent History

Delayed Upgrade Clock